“Successful Utilization of the GLP-1 Receptor Agonist Semaglutide in Treating the Manifestations of Recalcitrant Celiac Disease” (2025) Archives of Clinical and Biomedical Research, 9(5), pp. 392–395. Available at: https://fortunejournals.org/ojs/index.php/acbr/article/view/15136 (Accessed: 17 September 2026).